CDC31 Antibody

What is CDC31 and why are antibodies against it important in research?

CDC31 is the yeast homologue of centrin, a highly conserved calcium-binding protein belonging to the calmodulin superfamily. It plays crucial roles in multiple cellular processes, most notably in spindle pole body (SPB) duplication in yeast, which is analogous to centrosome duplication in higher eukaryotes . Antibodies against CDC31 are invaluable research tools that allow scientists to:

• Visualize the localization of CDC31 protein within cells

• Study protein-protein interactions involving CDC31

• Investigate the functional roles of CDC31 in various cellular processes

• Examine the consequences of CDC31 mutations on cell integrity and morphogenesis

The importance of CDC31 extends beyond SPB duplication, as mutations in CDC31 have been shown to affect cell integrity and morphology, suggesting multiple functional roles for this protein .

How can CDC31 protein be detected within yeast cells?

CDC31 protein can be reliably detected using affinity-purified anti-CDC31 antibodies through several techniques:

• Immunoelectron microscopy: This technique provides high-resolution visualization of CDC31 localization at the ultrastructural level. When performed on whole yeast cells or isolated SPBs, it allows precise determination of CDC31's position within the SPB complex .

• Immunofluorescence microscopy: When performed on isolated nuclei rather than whole cells, this approach yields stronger staining due to improved antigen accessibility. CDC31 typically appears as one or two distinct dots at the nuclear periphery, corresponding to the SPB locations .

• Immunoblotting: Anti-CDC31 antibodies can specifically detect CDC31 protein in yeast cell extracts, allowing quantification and assessment of expression levels .

For optimal results with immunofluorescence of isolated nuclei, researchers should resuspend the nuclei in buffer A (40 mM potassium phosphate, pH 6.5, 0.5 mM MgCl₂, 1.2 M sorbitol) and fix with 2% formaldehyde for 30-60 minutes .

How are CDC31 antibodies validated for specificity?

Ensuring antibody specificity is critical for reliable results. CDC31 antibodies should be validated through multiple approaches:

• Immunoblotting against purified proteins: Test the antibody against both purified CDC31 protein and related proteins like calmodulin to confirm specificity .

• Control experiments: Include parallel experiments with preimmune serum to establish baseline non-specific binding .

• Cross-reactivity testing: Evaluate potential cross-reactivity with other members of the calmodulin family to confirm target specificity .

The affinity-purified anti-CDC31 antibodies have been shown to give a positive signal with CDC31 but not with GST on immunoblots, demonstrating their high specificity . This validation is essential before proceeding with localization studies by immunofluorescence or immunoelectron microscopy.

What is the relationship between CDC31 and protein kinase Kic1p?

CDC31 physically interacts with Kic1p (kinase that interacts with CDC31p), a novel essential protein kinase of 1,080 residues that is closely related to S. cerevisiae Ste20p and p-21-activated kinases (PAKs) . This interaction has been confirmed through multiple lines of evidence:

• Two-hybrid screen: Initial identification of Kic1p as a CDC31-interacting protein .

• Co-precipitation assays: CDC31p co-precipitates with GST-Kic1p .

• Gel overlay assays: CDC31p binds to GST-Kic1p in these assays .

• Functional dependence: GST-Kic1p exhibits in vitro kinase activity that is CDC31-dependent .

Importantly, genetic studies have shown that cdc31 kic1 double mutants exhibit a severely restricted range of permissive temperature and pronounced lysis defects, indicating that Kic1p function is dependent upon CDC31p both in vivo and in vitro .

How do mutations in CDC31 affect cellular functions beyond SPB duplication?

While CDC31 was initially characterized for its role in SPB duplication, research has revealed additional functions:

• Cell integrity maintenance: CDC31 mutants exhibit lysis and morphological defects independent of SPB duplication issues .

• Morphogenesis regulation: CDC31 appears to influence cell morphology through its interaction with Kic1p .

• Protein kinase activity modulation: CDC31 is required for the proper functioning of Kic1p protein kinase, which impacts cell integrity pathways .

This multifunctionality suggests that CDC31 serves as a regulatory node connecting different cellular processes, similar to calmodulin in higher eukaryotes.

What is the recommended protocol for producing anti-CDC31 antibodies?

The following protocol has been successfully employed for generating specific anti-CDC31 antibodies:

• Expression construct creation: Create an in-frame fusion of the CDC31 coding region downstream of glutathione-S-transferase (GST) in an appropriate expression vector .

• Fusion protein production: Express the GST-CDC31 fusion protein in a suitable host system and purify using Glutathione Sepharose 4B column chromatography .

• Immunization: Raise antibodies against the GST-CDC31 fusion protein in rabbits following standard immunization protocols .

• Affinity purification:

  • Prepare affinity column by coupling purified CDC31 to CNBr-Sepharose 4B

  • Pass the IgG fraction containing anti-CDC31 antibodies through the column

  • Elute bound antibodies with 100 mM glycine, pH 2.5

  • Immediately adjust pH to 7.5 with 1 M Tris-HCl, pH 8.0

• Pre-adsorption: Adsorb antibodies on heated (70°C for 1 hour) yeast cells to remove non-specific binding .

This procedure yields highly specific anti-CDC31 antibodies suitable for immunoblotting, immunofluorescence, and immunoelectron microscopy applications.

What are the optimal conditions for immunoelectron microscopy with CDC31 antibodies?

For successful immunoelectron microscopy of CDC31:

• Sample preparation:

  • For whole yeast cells: Follow the protocol described by Preuss et al. (1991)

  • For isolated SPBs: Follow the protocol described by Pipe (1986)

• Antibody dilution: Use a 1:10 dilution of affinity-purified anti-CDC31 antibodies

• Gold particle visualization: Examine samples in a transmission electron microscope (e.g., Jeol JEM 100B)

• Controls: Include parallel samples processed with preimmune serum at the same dilution to assess non-specific binding

The gold particles revealing CDC31 localization should be concentrated at the SPB structure, particularly at specific regions depending on the cell cycle stage.

How can CDC31 antibodies be used to study CDC31-Kic1p interactions?

To investigate the interaction between CDC31 and Kic1p, researchers can employ several complementary approaches:

• Co-immunoprecipitation: Use anti-CDC31 antibodies to precipitate CDC31 and associated proteins, then probe for Kic1p in the precipitate .

• In vitro binding assays: Perform GST pulldown assays with GST-Kic1p and detect bound CDC31 using anti-CDC31 antibodies .

• Kinase activity assays: Test the kinase activity of Kic1p in the presence or absence of CDC31 to demonstrate functional dependence .

• Immunofluorescence co-localization: Use dual-labeling with anti-CDC31 antibodies and anti-Kic1p antibodies to examine potential co-localization in cells .

These techniques collectively provide strong evidence for physical and functional interactions between these proteins.

What factors influence the specificity of CDC31 antibody staining?

Several factors can affect the specificity of CDC31 antibody staining:

• Antibody purification: Affinity-purified antibodies show significantly higher specificity than crude serum .

• Pre-adsorption: Adsorbing antibodies on heated yeast cells reduces background staining .

• Fixation conditions: Formaldehyde concentration and fixation time affect epitope accessibility and preservation .

• Sample preparation: Using isolated nuclei rather than whole cells can improve signal strength for immunofluorescence due to better antigen accessibility .

• Antibody dilution: Optimal dilution must be determined empirically (typically 1:50 for immunoblotting and 1:10 for immunoelectron microscopy) .

For specificity validation, immunoblotting should show that the affinity-purified anti-CDC31 antibodies recognize CDC31 but not related proteins like calmodulin or GST .

How can researchers distinguish between CDC31-specific staining and non-specific background?

To differentiate specific CDC31 staining from background:

• Control antibodies: Always include parallel experiments with preimmune serum at the same or higher concentration .

• Competing antigens: Pre-incubate antibodies with purified CDC31 protein before staining to demonstrate binding specificity .

• Multiple detection methods: Confirm localization results using different techniques (e.g., immunofluorescence and immunoelectron microscopy) .

• Co-localization with known markers: For SPB localization, co-stain with established SPB markers like the 90-kD component, which serves as a reference point .

When properly optimized, CDC31 staining should appear as discrete dots at the nuclear periphery in immunofluorescence, corresponding to SPB locations .

How does CDC31 function in relation to other SPB components?

CDC31 functions as part of a complex network of SPB proteins:

• Localization pattern: CDC31 co-localizes with the 90-kD SPB component, appearing as one or two dots at the nuclear periphery .

• Functional separation: While CDC31 is critical for SPB duplication, Kic1p (which interacts with CDC31) is not required for this process, suggesting CDC31 participates in distinct functional pathways .

• Regulatory role: CDC31 appears to act as a calcium-sensing regulatory protein that influences both structural components of the SPB and signaling pathways through proteins like Kic1p .

Research suggests that CDC31's roles can be conceptually divided into structural functions at the SPB and regulatory functions through interactions with other proteins, similar to how calmodulin functions in higher eukaryotes.

What insights do comparative studies provide regarding CDC31 antibody epitopes across species?

While the search results don't directly address cross-species reactivity of CDC31 antibodies, we can infer important considerations:

• Conservation: As a member of the highly conserved centrin family, CDC31 shares significant homology with centrins in other organisms .

• Epitope selection: When developing antibodies intended for cross-species applications, targeting highly conserved regions of CDC31 would increase the likelihood of cross-reactivity.

• Validation requirements: Antibodies developed against yeast CDC31 must be specifically validated for each additional species where application is intended.

Researchers studying CDC31 homologs in other organisms should consider sequence alignment analysis to predict potential cross-reactivity of existing anti-CDC31 antibodies or to guide the development of new antibodies with desired species specificity.